Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials.

[1]  J. Popma,et al.  Impact of Smoking on Clinical and Angiographic Restenosis After Percutaneous Coronary Intervention: Another Smoker’s Paradox? , 2001, Circulation.

[2]  D. Baim,et al.  Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials , 2001, Circulation.

[3]  D. Baim,et al.  Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries. , 2001, The American journal of cardiology.

[4]  K Ulm,et al.  Restenosis after coronary placement of various stent types. , 2001, The American journal of cardiology.

[5]  M. Leon,et al.  Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. , 2001, The American journal of cardiology.

[6]  E. Edelman,et al.  Neutrophil, Not Macrophage, Infiltration Precedes Neointimal Thickening in Balloon-Injured Arteries , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[7]  P. Boekstegers,et al.  Influence of stent design on 1‐year outcome after coronary stent placement: A randomized comparison of five stent types in 1,147 unselected patients , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  J. Tanguay,et al.  Platelets and restenosis. , 2000, Journal of the American College of Cardiology.

[9]  P. D. de Feyter,et al.  Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I, BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter Ultrasound Stent In Coro , 1999, Journal of the American College of Cardiology.

[10]  Antonio Colombo,et al.  Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) , 1998, The Lancet.

[11]  M. Hadamitzky,et al.  Predictive factors of restenosis after coronary stent placement. , 1997, Journal of the American College of Cardiology.

[12]  P. Libby,et al.  The molecular bases of restenosis. , 1997, Progress in cardiovascular diseases.

[13]  E. Topol,et al.  Uncoupling clinical outcomes and coronary angiography: a review and perspective of recent trials in coronary artery disease. , 1996, American heart journal.

[14]  M. Leon,et al.  Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. , 1996, Circulation.

[15]  M. Leon,et al.  Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization. , 1996, Journal of the American College of Cardiology.

[16]  H Yokoi,et al.  Three-year follow-up after implantation of metallic coronary-artery stents. , 1996, The New England journal of medicine.

[17]  V. Burke,et al.  Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. , 1995, Circulation.

[18]  E. Topol,et al.  Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. , 1995, Circulation.

[19]  A. Marian,et al.  Angiotensin-I converting enzyme genotype DD is a risk factor for coronary artery disease. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[20]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[21]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[22]  S. Epstein,et al.  The basis of molecular strategies for treating coronary restenosis after angioplasty. , 1994, Journal of the American College of Cardiology.

[23]  D. Baim,et al.  Defining coronary restenosis. Newer clinical and angiographic paradigms. , 1993, Circulation.

[24]  C M Gibson,et al.  Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. , 1993, Journal of the American College of Cardiology.

[25]  P W Serruys,et al.  Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. , 1988, Circulation.

[26]  R E Vlietstra,et al.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. , 1984, The American journal of cardiology.

[27]  R. Asinger,et al.  A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes. , 1984, The American journal of cardiology.